MONTREAL, Feb. 13, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals (OTCBB:SPHC) and Samaritan Therapeutics, a Montreal research and development biotech company, minority owned by Samaritan Pharmaceuticals, is pleased to announce Dr. Wolfgang Renz as President of Samaritan Therapeutics to accelerate Samaritan Therapeutics’ innovative drug pipeline forward with Health Canada, Canada’s FDA equivalent.
